Telo Therapeutics
Pre-clinicalDeploying targeted protein degradation to unlock the full potential of nuclear transport inhibitors in oncology Telo Therapeutics is an oncology therapeutics company developing innovative targeted therapies to treat patients with cancers refractory to existing medicines. Our mission is to dramatically improve survival and well-being in cancer patients who have run out of treatment options. Telo Therapeutics
About
Deploying targeted protein degradation to unlock the full potential of nuclear transport inhibitors in oncology Telo Therapeutics is an oncology therapeutics company developing innovative targeted therapies to treat patients with cancers refractory to existing medicines. Our mission is to dramatically improve survival and well-being in cancer patients who have run out of treatment options. Telo Therapeutics
Funding History
1Total raised: $8M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile